Literature DB >> 9129915

Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study.

F Calais Da Silva1, P Marquis, P Deschaseaux, J L Gineste, J Cauquil, D L Patrick.   

Abstract

OBJECTIVE: Benign prostatic hyperplasia (BPH) and its treatment can impair the quality of life (QoL) of patients with the condition. Among the BPH-specific instruments available for assessing QoL, no consensus has emerged on the concepts that should be measured, particularly for aspects of sexual life. The objective of this study was to determine which aspects of QoL were most affected by prostatic symptoms and which patients considered the most important.
METHOD: After an extensive literature review, we drew up a self-administered questionnaire composed of an exhaustive list of concepts found in the available QoL/BPH measures. In a cross-sectional study, 73 French and 44 English patients with an International Prostate Score (I-PSS) > 7 were asked to fill in this 89-item questionnaire. The level of interference of the symptoms with each aspect of QoL and the importance of the problem were reported by the patients.
RESULTS: The aspects reported to be most affected and to be the most important were sleep, anxiety and worry about the disease, mobility, leisure, daily activities, sexual activities and satisfaction with sexual relationships. French patients considered all sexual aspects of life more important than English patients.
CONCLUSION: This study confirms that QoL is an important outcome in BPH. The major concepts identified by the patients to be important include sexual ones. These results suggest the importance of including the assessment of sexual functioning and behavior in any further evaluations of BPH treatments effects on QoL.

Entities:  

Mesh:

Year:  1997        PMID: 9129915     DOI: 10.1159/000474467

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  18 in total

Review 1.  Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression.

Authors:  L Zakaria; A G Anastasiadis; R Shabsigh
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life.

Authors:  Donald MacDonald; Thomas A McNicholas
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Side Effects of alpha-Blocker Use: Retrograde Ejaculation.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2009

Review 4.  Questionnaires to measure sexual quality of life.

Authors:  Renata Arrington; Joseph Cofrancesco; Albert W Wu
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

5.  Open-label, Intermittent Dose, Prospective Study Evaluating the Effects of Tadalafil on Lower Urinary Tract Symptoms and Erectile Function in Patients with Benign Prostatic Hyperplasia: Continuation and Durability of Effects.

Authors:  Tae-Beom Kim; Khae-Hawn Kim; Sang-Jin Yoon
Journal:  Int Neurourol J       Date:  2010-04-30       Impact factor: 2.835

Review 6.  Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions.

Authors:  J E Batista-Miranda; M D Diez; P A Bertrán; H Villavicencio
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  Quality of life and sexual function in patients with benign prostatic hyperplasia.

Authors:  Reginald C Bruskewitz
Journal:  Rev Urol       Date:  2003

8.  Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2005

9.  Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment.

Authors:  Mel P Daly
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

10.  Minimizing Sexual Dysfunction in BPH Surgery.

Authors:  Joon Yau Leong; Amir S Patel; Ranjith Ramasamy
Journal:  Curr Sex Health Rep       Date:  2019-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.